Skip to main content

Table 3 Data and analysis France, part 1

From: Pharmaco-economic impact of demographic change on pharmaceutical expenses in Germany and France

Alter

2004

2050

2004 in %

2050 in %

Pharma Expenses 1997

Partial Expenses 2004

Partial Expenses 2050

Change Expenses

0-9

7279,22

8658,88

12,15%

11,60%

210,44 €

25,58 €

24,41 €

-4,57%

10-19

7612,54

8513,59

12,71%

11,40%

143,91 €

18,29 €

16,41 €

-10,28%

20-29

7643,13

8306,88

12,76%

11,13%

222,42 €

28,38 €

24,75 €

-12,81%

30-39

8602,58

8583,24

14,36%

11,50%

310,69 €

44,63 €

35,72 €

-19,95%

40-49

8482,64

8176,95

14,16%

10,95%

411,76 €

58,32 €

45,10 €

-22,66%

50-59

7797,79

7787,49

13,02%

10,43%

770,93 €

100,37 €

80,42 €

-19,88%

60-69

5198,12

7813,66

8,68%

10,47%

1084,67 €

94,14 €

113,53 €

20,59%

70-79

4611,94

7219,29

7,70%

9,67%

1592,33 €

122,61 €

153,98 €

25,58%

>79

2665,04

9594,43

4,45%

12,85%

1613,83 €

71,81 €

207,41 €

188,83%

SUM

59893,00

74654,40

100,00%

100,00%

 

564,13 €

701,73 €

24,39%

  1. Source: Own analysis based on [4, 16].